Zenagamtide
amycretin · NNC0487-0111 · AMAZE 7
Obesity and metabolic pipeline. GLP-1 + amylin receptor agonist · Once-daily oral or once-weekly subcutaneous. 24 matched ClinicalTrials.gov records with status, phase, posted-results, country, US state, and site-level recruitment context.
